Fig. 1
From: IL-22 production of effector CD4+ T-cells is altered in SLE patients
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40001-019-0385-6/MediaObjects/40001_2019_385_Fig1_HTML.png)
A representative dot plot of CD4+CD134+ T-cells after ex vivo stimulation with phorbol myristate acetate and calcium ionophore (a). CD4+ T-cells were defined as CD3+CD8− T-cells. Next, CD4+CD134+ T-cells were analyzed for their ability to produce of IFN-γ, IL-21 and IL-22 in SLE patients (SLE) and healthy controls (HC). A representative dot plot of each condition is shown in b. The percentages of all experiments for SLE patients (n = 39) and HC (n = 19) are shown in c. Horizontal lines represent the mean value. Every symbol represents one measurement